Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study.
Abdel-Razeq H, Sharaf B, Al-Jaghbeer MJ, Abu-Fares H, Bater R, Shaer MA, Abu-Jaish H, Laban DA, Salamah O, Tamimi F, Ashouri K, Salameh T, Zughul R, Alhalaseh Y. Abdel-Razeq H, et al. Among authors: bater r. J Thromb Thrombolysis. 2023 Oct;56(3):447-453. doi: 10.1007/s11239-023-02860-4. Epub 2023 Jul 11. J Thromb Thrombolysis. 2023. PMID: 37430158
Patterns and predictors of thromboembolic events among patients with gastric cancer.
Abdel-Razeq H, Mustafa R, Sharaf B, Al-Tell A, Braik D, Ashouri K, Omari Z, Mansour R, Qarqash J, Shaqboua H, Jaradat S, Al-Qasem K, Bater R. Abdel-Razeq H, et al. Among authors: bater r. Sci Rep. 2020 Oct 28;10(1):18516. doi: 10.1038/s41598-020-75719-w. Sci Rep. 2020. PMID: 33116272 Free PMC article.
The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma.
Abdel-Razeq H, Ma'koseh M, Mansour A, Bater R, Amarin R, Abufara A, Halahleh K, Manassra M, Alrwashdeh M, Almomani M, Zmaily M. Abdel-Razeq H, et al. Among authors: bater r. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211045908. doi: 10.1177/10760296211045908. Clin Appl Thromb Hemost. 2021. PMID: 34590497 Free PMC article.
Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo-ECAG) ovarian study.
Abdel-Razeq H, Al-Azzam K, Elemian S, Abu-Fares H, Abu Sheikha A, Bani Hani H, Bater R, Sharaf B, Heald B, Esplin ED, Nielsen SM, Alkyam M, Abujamous L, Al-Attary A. Abdel-Razeq H, et al. Among authors: bater r. Mol Genet Genomic Med. 2023 Apr;11(4):e2125. doi: 10.1002/mgg3.2125. Epub 2022 Dec 19. Mol Genet Genomic Med. 2023. PMID: 36537080 Free PMC article.
Prevalence, Patterns, and Predictors of Venous Thromboembolic Events in Patients Undergoing Salvage Chemotherapy and Autologous Stem Cell Transplantation for Relapsed Lymphomas.
Ma'koseh M, Alrwashdeh M, Abdel-Razeq N, Alfar R, Edaily S, Bater R, Zmaily M, Almomani M, Abdel-Razeq H. Ma'koseh M, et al. Among authors: bater r. Hematol Oncol Stem Cell Ther. 2023 May 23;16(4):323-329. doi: 10.56875/2589-0646.1043. Hematol Oncol Stem Cell Ther. 2023. PMID: 37363978 Free article.
21 results